Kliogest

Norethisterone acetate and estradiol, the active ingredients in Kliogest, are a combined estrogen‑progestogen presented as an oral tablet for systemic use. They are indicated for contraception, menstrual regulation and hormone replacement therapy in women.

GNH USA supplies Kliogest as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kliogest, a combined estrogen‑progestogen, is used in hormonal pathways related to contraception and hormone replacement therapy.

- Prevention of pregnancy: provides reliable oral contraception for women of reproductive age. - Regulation of menstrual cycles: helps normalize cycle length and flow. - Management of menopausal symptoms (hormone replacement therapy): alleviates vasomotor symptoms and prevents bone loss.

Kliogest may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea or vomiting - Breast tenderness or enlargement - Headache or migraine - Mood swings or irritability - Weight gain or fluid retention - Spotting or breakthrough bleeding

Serious or Rare Side Effects: - Deep vein thrombosis or pulmonary embolism - Stroke or myocardial infarction - Severe hypertension - Liver dysfunction or jaundice - Allergic reactions such as rash, angioedema, or anaphylaxis

Before prescribing Kliogest, clinicians should evaluate individual risk factors and contraindications. - Thromboembolic risk: avoid in patients with a history of clotting disorders. - Cardiovascular disease: assess for hypertension, coronary artery disease, or stroke. - Liver disease: use with caution in hepatic impairment. - Smoking: discourage use in women over 35 who smoke. - Pregnancy: contraindicated; ensure effective contraception. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Kliogest can interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampin, carbamazepine) that may reduce hormonal levels. - Anticoagulants (e.g., warfarin) where estrogen may increase clotting risk.

Moderate Interactions (Monitor Closely): - Antiepileptic drugs (e.g., phenytoin) that may modestly lower contraceptive effectiveness. - Certain antibiotics (e.g., metronidazole) that can increase estrogen exposure. - Herbal supplements containing St. John's wort. - Selective serotonin reuptake inhibitors that may exacerbate mood changes.